Inamrinone

Excerpt

Inamrinone is a phosphodiesterase inhibitor for managing congestive heart failure (CHF). This course discusses inamrinone's indications, mechanism of action, administration modalities, and potential adverse events. Despite its efficacy for treating CHF, a waning adoption is noted due to associated side effects. Additionally, inamrinone's contraindications, clinical toxicity, and pharmacokinetics are evaluated, underscoring the necessity for vigilant monitoring during utilization.